1. Home
  2. RDHL vs AEMD Comparison

RDHL vs AEMD Comparison

Compare RDHL & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AEMD
  • Stock Information
  • Founded
  • RDHL 2009
  • AEMD 1984
  • Country
  • RDHL Israel
  • AEMD United States
  • Employees
  • RDHL N/A
  • AEMD N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AEMD Medical/Dental Instruments
  • Sector
  • RDHL Health Care
  • AEMD Health Care
  • Exchange
  • RDHL Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • RDHL 3.9M
  • AEMD 4.1M
  • IPO Year
  • RDHL N/A
  • AEMD N/A
  • Fundamental
  • Price
  • RDHL $1.51
  • AEMD $0.77
  • Analyst Decision
  • RDHL
  • AEMD Buy
  • Analyst Count
  • RDHL 0
  • AEMD 2
  • Target Price
  • RDHL N/A
  • AEMD $28.75
  • AVG Volume (30 Days)
  • RDHL 88.5K
  • AEMD 8.9M
  • Earning Date
  • RDHL 09-05-2025
  • AEMD 11-12-2025
  • Dividend Yield
  • RDHL N/A
  • AEMD N/A
  • EPS Growth
  • RDHL N/A
  • AEMD N/A
  • EPS
  • RDHL N/A
  • AEMD N/A
  • Revenue
  • RDHL $9,550,000.00
  • AEMD N/A
  • Revenue This Year
  • RDHL $381.91
  • AEMD N/A
  • Revenue Next Year
  • RDHL N/A
  • AEMD N/A
  • P/E Ratio
  • RDHL N/A
  • AEMD N/A
  • Revenue Growth
  • RDHL 157.62
  • AEMD N/A
  • 52 Week Low
  • RDHL $1.06
  • AEMD $0.60
  • 52 Week High
  • RDHL $11.70
  • AEMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 54.23
  • AEMD 40.20
  • Support Level
  • RDHL $1.22
  • AEMD $0.60
  • Resistance Level
  • RDHL $1.60
  • AEMD $0.82
  • Average True Range (ATR)
  • RDHL 0.08
  • AEMD 0.20
  • MACD
  • RDHL 0.04
  • AEMD -0.08
  • Stochastic Oscillator
  • RDHL 76.32
  • AEMD 11.55

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: